The new Federal Trade Commission chairwoman, Edith Ramirez, has placed the healthcare industry at the top of priorities for the regulator at a meeting attended by antitrust enforcers from around the globe. The decision to focus on healthcare reflects two major cases currently in the hands of the US Supreme Court: the so-called pay-for-delay controversy, and a recent hospital merger in Georgia. The first is expected to see a resolution by July and may change the competition landscape of generic and brand name drug makers. Concerning the hospital merger in Georgia, the Federal Trade Commission recently moved to block a deal where Phoebe Putney Memorial Hospital bought Palmyra Medical Center. The acquisition was completed in 2011 and the case currently before the Supreme Court revolves around whether the local hospital authority, which allowed the merger, trumps federal antitrust law.
Featured News
Toast Faces FTC Lawsuit Over Alleged Hidden Fees and Subscription Practices
Oct 29, 2026 by
CPI
Amazon, Uber and Instacart Challenge NYC Delivery Worker Protections in Federal Court
Oct 29, 2026 by
CPI
Wall Street Law Giant Weil Gotshal to Dissolve After Partner Exodus
Oct 29, 2026 by
CPI
DoorDash to Acquire Instacart in $17 Billion Grocery Delivery Deal
Oct 29, 2026 by
CPI
Anthropic Urges California to Give Courts Power to Block High-Risk AI Models
Oct 29, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Exclusive Dealing
Oct 25, 2026 by
CPI
Exclusive Dealing Without Exclusivity: Screening Contracts, Loyalty Rebates, and the Limits of Antitrust Tests
Oct 25, 2026 by
David Martimort & Jérôme Pouyet
When Competition for Exclusivity Raises Prices: Rebates, Pricing Rules, and the Insulin Puzzle
Oct 25, 2026 by
Daniel P. O’Brien & Greg Shaffer
Why Leaving the Door Open Can Be (Much) Worse Than Closing It: Share-Based Requirements, Buyer-Specific Costs, and Foreclosure
Oct 25, 2026 by
Zhijun Chen & Greg Shaffer
Antitrust Chronicle® – EU Merger Guidelines
Oct 19, 2026 by
CPI